JSPR · Categories · Form 4

JSPR - SEC Form 4 insider transactions

Jasper Therapeutics Inc. (JSPR) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for JSPR

• 119d
  SEC Form 4 filed by CEO and President Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 155d
  SEC Form 4 filed by President, CEO and Director Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 155d
  SEC Form 4 filed by Chief Operating Officer Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 155d
  SEC Form 4 filed by Chief Financial Officer Cross Herb

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 341d
  SEC Form 4 filed by Director Brun Scott C.

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 341d
  SEC Form 4 filed by Director Emster Kurt Von

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 341d
  SEC Form 4 filed by Director Shizuru Judith Anne

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 341d
  SEC Form 4 filed by Director Nolet Chris

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 341d
  SEC Form 4 filed by Director Kapoor Vishal

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 341d
  SEC Form 4 filed by Director Wiggans Thomas G

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 341d
  SEC Form 4 filed by Director Lucas Svetlana

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 369d
  SEC Form 4 filed by President and CEO Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 369d
  SEC Form 4 filed by Chief Operating Officer Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 369d
  SEC Form 4 filed by Chief Financial Officer Cross Herb

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 369d
  SEC Form 4 filed by Chief Medical Officer Tucker Edwin Jonathan

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 476d
  SEC Form 4 filed by Chief Operating Officer Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 476d
  SEC Form 4 filed by President, CEO and Director Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 476d
  SEC Form 4 filed by Chief Financial Officer Cross Herb

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 476d
  SEC Form 4 filed by Chief Medical Officer Tucker Edwin Jonathan

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 544d
  Chief Operating Officer Mahal Jeetinder Singh sold $19,899 worth of Voting Common Stock (900 units at $22.11) and exercised 900 units of Voting Common Stock at a strike of $7.10 (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 635d
  Chief Operating Officer Mahal Jeetinder Singh exercised 900 units of Voting Common Stock at a strike of $7.10 and sold $19,104 worth of Voting Common Stock (900 units at $21.23) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 720d
  SEC Form 4 filed by Director Lucas Svetlana

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 727d
  Chief Operating Officer Mahal Jeetinder Singh exercised 900 units of Voting Common Stock at a strike of $7.10 and sold $21,740 worth of Voting Common Stock (900 units at $24.16) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 727d
  SEC Form 4 filed by President, CEO and Director Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 729d
  Chief Medical Officer Tucker Edwin Jonathan was granted 400 units of Voting Common Stock (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 729d
  SEC Form 4 filed by Director French Anna Louise

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 729d
  SEC Form 4 filed by Director Nolet Chris

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 729d
  SEC Form 4 filed by Director Shizuru Judith Anne

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 729d
  SEC Form 4 filed by Director Kapoor Vishal

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 729d
  SEC Form 4 filed by Director Wiggans Thomas G

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 729d
  SEC Form 4 filed by Director Brun Scott C.

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 729d
  SEC Form 4 filed by Director Emster Kurt Von

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 819d
  Mahal Jeetinder Singh exercised 900 units of Voting Common Stock at a strike of $7.10 and sold $23,792 worth of Voting Common Stock (900 units at $26.44) (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 840d
  SEC Form 4 filed by Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 840d
  SEC Form 4 filed by Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 840d
  SEC Form 4 filed by Cross Herb

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 840d
  SEC Form 4 filed by Tucker Edwin Jonathan

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 950d
  SEC Form 4 filed by Wiggans Thomas G

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 970d
  Mahal Jeetinder Singh covered exercise/tax liability with 37,126 units of Voting Common Stock, decreasing direct ownership by 13% to 250,097 units (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 970d
  Martell Ron covered exercise/tax liability with 87,531 units of Voting Common Stock, decreasing direct ownership by 21% to 331,188 units (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 970d
  Lis William sold $6,777 worth of Voting Common Stock (7,965 units at $0.85), decreasing direct ownership by 13% to 53,521 units (SEC Form 4)

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 987d
  SEC Form 4 filed by Cross Herb

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1085d
  SEC Form 4 filed by Brun Scott C.

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1092d
  SEC Form 4 filed by Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1092d
  SEC Form 4 filed by Tucker Edwin Jonathan

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1097d
  SEC Form 4 filed by Kapoor Vishal

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1097d
  SEC Form 4 filed by Klein Lawrence Otto

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1097d
  SEC Form 4 filed by Emster Kurt Von

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1097d
  SEC Form 4 filed by Shizuru Judith Anne

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1097d
  SEC Form 4 filed by Nolet Chris

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1097d
  SEC Form 4 filed by Lis William

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1097d
  SEC Form 4 filed by French Anna Louise

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1152d
  SEC Form 4 filed by French Anna Louise

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1152d
  SEC Form 4 filed by Emster Kurt Von

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1152d
  SEC Form 4 filed by Martell Ron

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1152d
  SEC Form 4 filed by Mahal Jeetinder Singh

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1152d
  SEC Form 4 filed by Lis William

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1155d
  SEC Form 4 filed by Qiming U.S. Healthcare Fund Ii, L.P.

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1177d
  SEC Form 4 filed by Jasper Therapeutics Inc.

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)
• 1177d
  SEC Form 4 filed by Jasper Therapeutics Inc.

  4 - Jasper Therapeutics, Inc. (0001788028) (Issuer)

Other JSPR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends